Antihyperlipidemic, anti-inflammatory, analgesic, and antipyretic activities of 'dimethyl dimethoxy biphenyl dicarboxylate' in male Wistar rats

Heba M.I. Abdallah, Gihan F. Asaad, Mahmoud S. Arbid, Yousra A. Nomier*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

Dimethyl dimethoxy biphenyl (DDB) dicarboxylate has been applied as a therapeutic modality for curing liver diseases, particularly hepatitis virus. The objective of this study was to assess the protective potential against Triton X-100 induced abnormal fat metabolism in addition to anti-inflammatory, analgesic, and antipyretic effects of DDB. The anti-inflammatory, antinociceptive, and antipyretic of DDB were investigated through induction of paw edema, pain, and fever in experimental rats. DDB decreased cholesterol and triglyceride contents. DDB resulted in inhibition of inflammation, nociception, and fever in the experimental models. DDB improved lipid profile, as evidence of hypolipidemic potential. It also showed anti-inflammatory, analgesic, and antipyretic properties.

Original languageEnglish
Pages (from-to)83-88
Number of pages6
JournalJournal of Advanced Pharmaceutical Technology and Research
Volume13
Issue number2
DOIs
Publication statusPublished - Apr 1 2022

Keywords

  • Analgesic
  • Triton X-100
  • anti-inflammatory
  • antihyperlipidemic
  • antipyretic
  • dimethyl dimethoxy biphenyl dicarboxylate

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this